Resources

Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 1

Wave 2 of this Tracking Report is now available here!

With the recent outbreak of the novel coronavirus (COVID-19) in the US, InCrowd wanted to understand how patients with chronic conditions and those who are immunocompromised have been impacted by the virus, and how they anticipate ways in which their lives and disease management will be affected moving forward.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method: 9-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illness
  • Sample Size: n=152 (77 Mild to Moderate Patients, 75 Moderate to Severe Patients)
  • Fielding Period: March 25-26, 2020

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Name(Required)
This field is for validation purposes and should be left unchanged.

Related Resources

Five Ways to Improve MedTech DTC Patient Engagement

Five Ways to Improve MedTech DTC Patient Engagement

US Patient & Physician Perspectives For this year's DTC National Conference, InCrowd wanted to demonstrate the ways in which diabetic patients perceive DTC ads for medical devices designed to help treat their condition. We also examined how treating...

read more
Pre-ASCO Excitement Report

Pre-ASCO Excitement Report

Instant Insights It’s just 3 weeks until ASCO (American Society of Clinical Oncology’s annual meeting), and oncologists have shared with us the agenda topics that most interest them. Immunotherapies topped the list, with CAR-T the most popular among them. Take a look...

read more